Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Denise Pollard-Knight

Affiliations

  • Director at Elanco Animal Health Inc (ELAN), 2019-04-12
  • Director at Oncomed Pharmaceuticals Inc (OMED), 2018-06-25
  • Large Shareholder, Director at Albireo Pharma Inc. (ALBO), 2017-06-20
  • Director at Idenix Pharmaceuticals Inc (IDIX), 2014-08-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMED $17.00 58,824 Director 2,122,807 2013-07-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMED $21.66 3,799 Director 1,943,509 2014-12-31 Filing
OMED $21.65 5,510 Director 1,947,308 2014-12-30 Filing
OMED $21.62 9,902 Director 1,952,818 2014-12-29 Filing
OMED $21.65 2,195 Director 1,962,720 2014-12-26 Filing
OMED $21.71 20,654 Director 1,964,915 2014-12-19 Filing